NCOA3 and breast carcinoma: PTPRN2, MERTK, TNC and SOX4 were identified to be targets of miR-335 [15], AIB1 and CCND1 were the targets of miR-17-5p [35], and H-RAS and HMGA2 were verified as targets of let-7 [36] in breast cancer.